Patents
Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
04/2005
04/13/2005CN1196683C Amino-compound
04/13/2005CN1196682C 4-pyridinyl-N-acyl-L-phenylalanines
04/13/2005CN1196675C Preparation of alum antimonate catalyst using tin dioxide hydrate
04/13/2005CN1196464C Novel coloring agent for use in oxidative hair dyeing
04/12/2005US6878828 Coupling cysteine with benzonitrile, then esterifying, alkylating, hydrolyzing and reacting with acids to form 2-methylcysteine
04/12/2005US6878750 Benzocycloheptenes, process for their production, pharmaceutical preparations that contain the latter as well as their use for the production of pharmaceutical agents
04/12/2005US6878743 Controlling apoptosis; central nervous system disorders
04/12/2005US6878724 Polyarylcarboxamides useful as lipid lowering agents
04/12/2005US6878720 VEGF receptor tyrosine kinase inhibitors
04/12/2005US6878718 Able to inhibit the binding of integrins to their ligands and are of use in the prophylaxis and treatment of immuno or inflammatory disorders
04/12/2005US6878714 Prophylaxis and treatment of angiogenesis mediated diseases such as cancer
04/12/2005US6878707 Carboxamides useful as inhibitors of microsomal triglyceride transfer protein and of apolipoprotein b secretion
04/12/2005US6878704 Heterocyclic mutilin esters and their use as antibacterials
04/12/2005US6878700 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
04/12/2005CA2203936C Boronic ester and acid compounds, synthesis and uses
04/07/2005WO2005030979A2 Dark quenchers for fluorescence resonance energy transfer (fret) in bioassays
04/07/2005WO2005030784A1 Photoacid generator
04/07/2005WO2005030766A1 Phenyl - carboxamide compounds useful for treating pain
04/07/2005WO2005030758A1 Pyrimidine and pyridine derivatives useful as hmg-coa reductase inhibitors and method of preparation thereof
04/07/2005WO2005030753A2 Therapeutic agents useful for treating pain
04/07/2005WO2005030736A1 Derivatives of 1,3-diones having a herbicidal activity
04/07/2005WO2005030723A1 Pyridylacetylenes for use as radiotracers and imaging agents
04/07/2005WO2005030705A1 Inhibitors of histone deacetylase
04/07/2005WO2005030704A1 Inhibitors of histone deacetylase
04/07/2005WO2005030694A1 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs
04/07/2005WO2005030213A1 1,1,1-trifluoro-4-phenyl-4-methyl-2-(1h-pyrrolo
04/07/2005WO2005019147A3 Pesticidally active phenol derivatives
04/07/2005WO2004110364A9 Thiotungstate analogues and uses thereof
04/07/2005WO2004096818A3 Method and compositions for identifying anti-hiv therapeutic compounds
04/07/2005WO2004014871A8 Vanilloid receptor ligands and their use in treatments
04/07/2005WO2003028728A8 4-(4-substituted piperazinyl-1yl)-butylcarboxamides as d3 dopamine subtype selective ligands
04/07/2005US20050075512 Diamine derivatives, process for producing the same, and bactericide containing the same as active ingredient
04/07/2005US20050075453 Method for producing aqueous polymer dispersions containing colorants
04/07/2005US20050075394 Phenethanolamine derivatives for treatment of respiratory diseases
04/07/2005US20050075392 cyclopentyl substituted glutaramide derivatives; inhibitors of neutral endopeptidase which may be used to treat cardiovascular disorders, especially hypertension
04/07/2005US20050075390 HIV protease inhibitors
04/07/2005US20050075378 Modulators of peroxisome proliferator activated receptors (ppar)
04/07/2005US20050075374 Sulfonyl aryl or heteroaryl hydroxamic acid compounds
04/07/2005US20050075372 Method for controlling particular insect pest by applying anthranilamide compounds
04/07/2005US20050075367 Ester compound and medicinal use thereof
04/07/2005US20050075332 Tricyclic compounds with antiviral activity
04/07/2005US20050075331 Viricides for infections caused by an RNA-containing virus; enzyme inhibitors for a hepatitis C virus (HCV) polymerase; inhibiting HCV viral replication; liver cirrhosis; e. g., 1-[2-(1-cyclohexen-1-yl)ethyl]-3-(1,1- ioxido-4H-1,2,4-benzo- thiadiazin-3-yl)-4-hydroxy-1,8-naphthyridin-2(1H)-one
04/07/2005US20050074668 Perfluorinated amide salts and their uses as ionic conducting materials
04/07/2005US20050074631 Luminescent efficiency and a long luminescent life
04/07/2005DE4330281B4 Verfahren zur Insektenbekämpfung Method for insect control
04/07/2005DE19845402B4 Mit Heterocyclen substituierte Propanolaminderivate, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung -Containing heterocycles substituted with Propanolaminderivate, process for their production, medicaments containing these compounds and their use
04/07/2005CA2539744A1 Derivatives of 1,3-diones having a herbicidal activity
04/07/2005CA2539403A1 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs
04/07/2005CA2539117A1 Inhibitors of histone deacetylase
04/07/2005CA2537010A1 Phenyl - carboxamide compounds useful for treating pain
04/07/2005CA2537004A1 Therapeutic agents useful for treating pain
04/06/2005EP1520472A2 Herbicidal compositions comprising pyridoyl-1,3-cyclodiones
04/06/2005EP1520452A2 Electronic devices made with electron transport and/or anti-quenching layers
04/06/2005EP1520308A2 Polymeric charge transport compositions and electronic devices made with such compositions
04/06/2005EP1520305A2 Charge transport compositions and electronic devices made with such compositions
04/06/2005EP1519936A1 Improved method of making nevirapine
04/06/2005EP1519935A2 Charge transport compositions comprising fluorinated phenanthroline derivatives
04/06/2005EP1519932A1 Bisarylsulfonamide compounds and their use in cancer therapy
04/06/2005EP1519922A1 Di-aryl-substituted ethane pyridone pde4 inhibitors
04/06/2005EP1519921A2 Substituted anthranilic amide derivatives and methods of use
04/06/2005EP1519915A2 Tricyclic steroid hormone nuclear receptor modulators
04/06/2005EP1392656A4 Process for preparing chiral diol sulfones and dihydroxy acid hmg coa reductase inhibitors
04/06/2005EP0960096B1 Substituted beta-thiocarboxylic acids
04/06/2005CN1604894A 经取代的苯基衍生物 Substituted phenyl derivatives
04/06/2005CN1604893A Cyclic amine compounds
04/06/2005CN1604891A Improved methods of ortho alkylation
04/06/2005CN1604774A 血管生成抑制剂 An angiogenesis inhibitor
04/06/2005CN1603310A Method for making 3-cyanopyridine in reactor
04/06/2005CN1603307A Cyanoacrylate derivatives and their preparation method and biological activity
04/06/2005CN1195738C 2'-substd. 1, 1'-biphenyl-2-carbonamides, method for production thereof, use thereof as medicament and pharmaceutical preparation contg. said compounds
04/06/2005CN1195737C HIV proteinase inhibitor
04/06/2005CN1195734C Phthalamide derivs., intermediates in production thereof, and agricultural/horticultural insecticides and method of using same
04/06/2005CN1195547C Preventives / remedies for glaucoma
04/05/2005US6875884 Urea derivatives as inhibitors for CCR-3 receptor
04/05/2005US6875883 Forming a phenyl-thiazoles chemical intermediates for making antioxidants, ferrielectric liquid crystal dopant, picornaviral viricides, antiinflammatory agents, anti-asthma agents, and fibringoen antagonists
04/05/2005US6875882 Ferroelectric liquid crystals, antihistamines, antiinflammatory agents, viricides
04/05/2005US6875867 Process for preparing chiral diol sulfones and dihydroxy acid HMG CoA reductase inhibitors
04/05/2005US6875781 Pyridines and uses thereof
04/05/2005US6875780 Compounds that modulate PPAR activity and methods for their preparation
04/05/2005US6875768 Phthalamide derivatives, intermediates in the production thereof, and agricultural/horticultural insecticides and method for using the same
04/05/2005US6875764 Urea and thiourea compounds useful for treatment of coccidiosis
04/05/2005US6875760 Glucagon antagonists/inverse agonists
04/05/2005US6875523 Photoactive lanthanide complexes with phosphine oxides, phosphine oxide-sulfides, pyridine N-oxides, and phosphine oxide-pyridine N-oxides, and devices made with such complexes
04/05/2005CA2141209C Novel pyridyl- and pyrimidylpiperazine derivatives
03/2005
03/31/2005WO2005028442A2 2-pyridinone derivatives, having hiv inhibiting properties
03/31/2005WO2005028439A1 Cinnamoyl compound and use of the same
03/31/2005WO2005028429A2 Haloalkyl containing compounds as cysteine protease inhibitors
03/31/2005WO2005028426A1 Novel 4-phenylamino-benzaldoxime derivative and use thereof as mek inhibitor
03/31/2005WO2005014581A3 Lanthanide complexes preparation and uses thereof
03/31/2005WO2005014545A3 N-′2-(2-pyridinyl) ethylbenzamide compounds and their use as fungicides
03/31/2005WO2005009961A3 Fluoro substituted omega-carboxyaryl diphenyl urea for the treatment and prevention of diseases and conditions
03/31/2005WO2004084824A3 Biaryl substituted 6-membered heterocyles as sodium channel blockers
03/31/2005WO2004073606A3 Sulfonamide derivatives as ppar modulators
03/31/2005US20050070717 Halogen-free ionic liquids
03/31/2005US20050070716 Method of synthesizing alkenone compounds
03/31/2005US20050070715 Methods for synthesis of acyloxyalkyl compounds
03/31/2005US20050070709 dealkylation of a benzodioxane aniline in presence of chloroethanol
03/31/2005US20050070582 For example,1-{[2-(3,5-dimethylphenoxy)-5-nitrophenyl]sulfonyl}-4-ethylpiperazine or 1-{[2-(3,5-dichlorophenoxy)-5-nitrophenyl]sulfonyl}piperazine; for the treatment of asthma, atopic dermatitis, allergic rhinitis and other inflammatory/immunological disorders
03/31/2005US20050070533 Substituted thiazole-benzoisothiazole dioxide derivatives, process for their preparation and their use
03/31/2005US20050070532 Peroxisome proliferator activated receptors (PPARS); for inhibiting formation of adipocytes; for treatment of obesity, diabetes, hyperinsulinemia, and polycystic ovary syndrome